Welcome!

You have landed on the personal website of Anran Chen, a scientist at the intersection of cancer molecular biology, technology, and entrepreneurship.

• Senior Scientist in oncology discovery at Bayer (FRA: BAYN) and former Senior Scientist in bioinformatics at Repare Therapeutics (NASDAQ: RPTX). I use data, biology, and strategic thinking to pinpoint novel targets for cancer treatment.
• BA in Natural Sciences from the University of Cambridge and PhD in Molecular and Biomedical Sciences from Baylor College of Medicine. My PhD research focused on understanding the resistance mechanisms in ER+ breast cancer. Both of my works on PKMYT1 and NF1 are featured at BCM news!
• Contributor to InScienceWeTrust Community. Check out my article on the KRAS landscape and share your thoughts!
• Avid explorer for state-of-the-art AI models such as chatGPT5 and Stable Diffusion. Fun fact: all images on this site are generated or improved by AIs!
• Passionate about how technology and science drive the future of investment and business. (And yes, I enrolled in the CFA program and cleared the Level I exam in November 2024)
• Team-worker and leader who have organized and hosted various events. I currently co-lead the Boston Chapter of CAMentrepreneur, an inclusive Cambridge University alumni network dedicated to fostering entrepreneurship. Join us by connecting through our LinkedIn Group.
• Connect with me on LinkedIn to discuss science, innovation, and entrepreneurship, or find my publications on ResearchGate.